Cyclerion Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cyclerion Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2019 to Q2 2024.
  • Cyclerion Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 2.71M shares, a 12.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 2.71M +299K +12.4% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 2.71M -40.8M -93.8% Mar 3, 2024 10-K 2024-03-05
Q3 2023 2.45M -41M -94.4% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 2.41M -41.1M -94.5% Jul 24, 2023 10-Q 2023-07-28
Q1 2023 43.5M +76.5K +0.18% Mar 19, 2023 10-K 2023-03-22
Q3 2022 43.5M +178K +0.41% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 43.5M +203K +0.47% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 43.4M +9.31M +27.3% May 2, 2022 10-Q 2022-05-04
Q3 2021 43.3M +9.35M +27.5% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 43.3M +9.36M +27.6% Jul 27, 2021 10-Q/A 2021-08-27
Q1 2021 34.1M +6.38M +23% Apr 27, 2021 10-Q/A 2021-08-27
Q3 2020 34M +6.49M +23.6% Nov 3, 2020 10-Q 2020-11-05
Q2 2020 33.9M +6.5M +23.7% Jul 29, 2020 10-Q 2020-08-03
Q1 2020 27.8M +353K +1.29% Mar 5, 2020 10-K 2020-03-12
Q3 2019 27.5M Nov 6, 2019 10-Q 2019-11-12
Q2 2019 27.4M Aug 12, 2019 10-Q 2019-08-12
Q1 2019 27.4M May 8, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.